These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 7907293

  • 1. Binding of adenosine deaminase to the lymphocyte surface via CD26.
    De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P, Scharpé S.
    Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
    [Abstract] [Full Text] [Related]

  • 2. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J, Olek S, Fleischer B, von Bonin A.
    Cell Immunol; 1999 Feb 25; 192(1):33-40. PubMed ID: 10066344
    [Abstract] [Full Text] [Related]

  • 3. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
    Sharoyan S, Antonyan A, Mardanyan S, Lupidi G, Cristalli G.
    Acta Biochim Pol; 2006 Feb 25; 53(3):539-46. PubMed ID: 16929383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster.
    de Meester I, Scharpé S, Vanham G, Bosmans E, Heyligen H, Vanhoof G, Corte G.
    Immunobiology; 1993 Jun 25; 188(1-2):145-58. PubMed ID: 8104877
    [Abstract] [Full Text] [Related]

  • 7. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
    Blanco J, Marié I, Callebaut C, Jacotot E, Krust B, Hovanessian AG.
    Exp Cell Res; 1996 May 25; 225(1):102-11. PubMed ID: 8635502
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
    Yu DM, Slaitini L, Gysbers V, Riekhoff AG, Kähne T, Knott HM, De Meester I, Abbott CA, McCaughan GW, Gorrell MD.
    Scand J Immunol; 2011 Feb 25; 73(2):102-11. PubMed ID: 21198750
    [Abstract] [Full Text] [Related]

  • 13. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
    Valenzuela A, Blanco J, Callebaut C, Jacotot E, Lluis C, Hovanessian AG, Franco R.
    J Immunol; 1997 Apr 15; 158(8):3721-9. PubMed ID: 9103436
    [Abstract] [Full Text] [Related]

  • 14. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV).
    Vivier I, Marguet D, Naquet P, Bonicel J, Black D, Li CX, Bernard AM, Gorvel JP, Pierres M.
    J Immunol; 1991 Jul 15; 147(2):447-54. PubMed ID: 1712807
    [Abstract] [Full Text] [Related]

  • 15. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.
    Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AN.
    J Exp Med; 1993 Apr 01; 177(4):1135-43. PubMed ID: 8096237
    [Abstract] [Full Text] [Related]

  • 16. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
    Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C.
    Science; 1993 Jul 23; 261(5120):466-9. PubMed ID: 8101391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
    Hegen M, Camerini D, Fleischer B.
    Cell Immunol; 1993 Feb 23; 146(2):249-60. PubMed ID: 7909722
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.